Clinical Trial Update: A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immunization responses in adults and adolescents with moderate-to-severe atopic dermatitis treated with nemolizumab has completed, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Nemolizumab (nemolizumab)

Snippet

Sponsor: Galderma R&D | Conditions: Dermatitis, Atopic | Phase 2 | Status: COMPLETED | Results posted: 2025-06-05